Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702

NCT00950586 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline